Literature DB >> 1923771

In vitro and in vivo analysis of the c-myc RNA polymerase III promoter.

D J Sussman1, J Chung, P Leder.   

Abstract

The c-myc promoter has the unusual property of displaying both RNA polymerase II (Pol II) and RNA polymerase III (Pol III) activities. Both Pol II and Pol III utilize the same transcription initiation site. We have now examined the effects of mutations in crucial regions of the c-myc promoter to assess their effects on both transcriptional activities. In doing this we show that both Pol II and Pol III activities require sequences that are located within the stronger of the two principal c-myc promoter regions (P2). Further, we show that the Pol III activity using this initiation site does not require an A box or distal upstream sequences. Like the Pol II activity, it does require an intact TATA sequence and alterations at this site result in the simultaneous loss of both Pol II and Pol III activities. The superimposition of two apparently inseparable promoter activities makes it possible to consider common features, possible common protein elements in each holoenzyme complex, as well as a potential role for each enzyme in the regulated expression of the c-myc gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923771      PMCID: PMC328808          DOI: 10.1093/nar/19.18.5045

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Functional distinctions between yeast TATA elements.

Authors:  P A Harbury; K Struhl
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

2.  Purified octamer binding transcription factors stimulate RNA polymerase III--mediated transcription of the 7SK RNA gene.

Authors:  S Murphy; A Pierani; C Scheidereit; M Melli; R G Roeder
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

3.  Activation of mouse genes in transformed cells.

Authors:  M R Scott; K H Westphal; P W Rigby
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

4.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.

Authors:  J Campisi; H E Gray; A B Pardee; M Dean; G E Sonenshein
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

6.  Factor substitution in a human HSP70 gene promoter: TATA-dependent and TATA-independent interactions.

Authors:  I C Taylor; R E Kingston
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Induction of the synthesis of a 70,000 dalton mammalian heat shock protein by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

9.  Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates.

Authors:  P A Weil; J Segall; B Harris; S Y Ng; R G Roeder
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  11 in total

1.  Repression of host RNA polymerase II transcription by herpes simplex virus type 1.

Authors:  C A Spencer; M E Dahmus; S A Rice
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Close association of RNA polymerase II and many transcription factors with Pol III genes.

Authors:  Debasish Raha; Zhong Wang; Zarmik Moqtaderi; Linfeng Wu; Guoneng Zhong; Mark Gerstein; Kevin Struhl; Michael Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-05       Impact factor: 11.205

3.  RNA polymerase III accurately initiates transcription from RNA polymerase II promoters in vitro.

Authors:  Sascha H C Duttke
Journal:  J Biol Chem       Date:  2014-06-10       Impact factor: 5.157

4.  TATA elements direct bi-directional transcription by RNA polymerases II and III.

Authors:  W Huang; J M Wong; E Bateman
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

5.  Transcription of human 5S rRNA genes is influenced by an upstream DNA sequence.

Authors:  J N Nielsen; C Hallenberg; S Frederiksen; P D Sørensen; B Lomholt
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

6.  Evolutionary selection against change in many Alu repeat sequences interspersed through primate genomes.

Authors:  R J Britten
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

7.  A CBF5 mutation that disrupts nucleolar localization of early tRNA biosynthesis in yeast also suppresses tRNA gene-mediated transcriptional silencing.

Authors:  A Kendall; M W Hull; E Bertrand; P D Good; R H Singer; D R Engelke
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

8.  The selenocysteine tRNA gene in leishmania major is transcribed by both RNA polymerase II and RNA polymerase III.

Authors:  Norma E Padilla-Mejía; Luis E Florencio-Martínez; Rodrigo Moreno-Campos; Juan C Vizuet-de-Rueda; Ana M Cevallos; Rosaura Hernández-Rivas; Rebeca Manning-Cela; Santiago Martínez-Calvillo
Journal:  Eukaryot Cell       Date:  2014-12-29

9.  tRNA genes as transcriptional repressor elements.

Authors:  M W Hull; J Erickson; M Johnston; D R Engelke
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  Unusual properties of adenovirus E2E transcription by RNA polymerase III.

Authors:  Wenlin Huang; S J Flint
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.